In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 8, 1996, Pages 678-682

  Fuchs, P C ^a   Barry, A L ^b   Brown, S D ^a   Sewell, D L ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; ENTEROBACTERIACEAE; ENTEROCOCCUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS;

EID: 0029844821     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691159     Document Type: Article

References (8)

1. Gooding BB, Jones RN: In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone. Antimicrobial Agents and Chemotherapy 1993, 37: 349-353.
2. Neu HC, Chin N: In vitro activity of the new fluoroquinolone CP-99,219. Antimicrobial Agents and Chemotherapy 1994, 38: 2615-2622.
3. Eliopoulos GM, Klimm K, Eliopoulos CT, Ferraro MJ, Moellering RC Jr: In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrobial Agents and Chemotherapy 1993, 37: 366-370.
4. Spangler SK, Jacobs MR, Appelbaum PC: Activity of CP-99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrobial Agents and Chemotherapy 1994, 38: 2471-2476.
5. National Committee for Clinical Laboratory Standards: Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA, 1993.
6. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A5. NCCLS, Villanova, PA, 1993.
7. Metzler CM, DeHaan RM: Susceptibility of anaerobic bacteria: statistical and clinical considerations. Journal of Infectious Diseases 1979, 130: 588-596.
8. Jones RN: Preliminary interpretive criteria for in vitro susceptibility testing of CP-99,219 by dilution and disk diffusion methods. Diagnostic Microbiology and Infectious Disease 1994, 20: 167-170.